Having regard to Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code relating to medicinal products for human use(1), and in particular Article 111b(2) thereof, | 32013D0051 — European Union law | Esheria

Having regard to Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code relating to medicinal products for human use(1), and in particular Article 111b(2) thereof,

The Commission must use specified EU guidelines and assess defined factors when evaluating a third country’s rules and controls for active substances exported to the Union.

AI-assisted research synopsis — verify against the official legal text below.

Jurisdiction
European Union
Instrument
Directive
Citation
32013D0051
Status
In force
Version
Undated source snapshot
Language
en
Official source
View official record ↗
manufacturing controls pharmaceutical compliance regulatory assessment

Publicly available, excluded from search-engine indexing

This page remains available for direct access and API use, but this release emits noindex,follow for the following reason:

  • The record does not meet this release's canonical indexing criteria. (market-indexing-disabled)

Statute overview

About this statute

This page preserves the statute’s identified version, provision structure, official source link, and stored legal text for reading and research.